Showing 10 of 36 Clinical Trials

• A011801 CompassHER2

  Breast Cancer Accepting Patients

  COMPASS HER2 Trials Examining Escalating and De-Escalating Therapy in HER2-positive Breast Cancer: Optimizing Treatment in Residual Disease (COMPASS HER2-RD): A Double-Blinded, Phase III Randomized Trial

• A012103 OptimICE-pCR

  Breast Cancer Accepting Patients

  De-escalation of therapy in early-stage TNBC patients who achieve pCR after neoadjuvant chemotherapy with checkpoint inhibitor therapy.

• A012301 LoTam

  Breast Cancer Not Accepting Patients

  A Randomized, Phase III Clinical Trial of Low-Dose Tamoxifen for Selected Patients with Molecular Low-risk Early-Stage Breast Cancer.

• A012303 ShortStop-HER2

  Breast Cancer Accepting Patients

  Shortened Duration of Adjuvant Therapy in patients with early-stage HER2+ Breast Cancer who achieve pCR after neoadjuvant chemotherapy with HER2 blockade.

• A041202 CLL

  Leukemia Not Accepting Patients

  A Randomized Phase III Study of Bendamustine Plus Rituximab Versus Ibrutinib Plus Rituximab Versus Ibrutinib alone in untreated older patients with Chronic Lymphocytic Leukemia (CLL)

• A212102

  Cancer Accepting Patients

  A212102 Blinded Reference Set for Multicancer Early Detection Blood Tests

• ACURATE IDE

  Valve Stenosis Not Accepting Patients

  ACURATE IDE: Transcatheter Replacement of Stenotic Aortic Valve through Implantation of ACURATE in Subjects Indicated for TAVR.

• ALCHEMIST A081801

  Lung Cancer Accepting Patients

  ALCHEMIST: A081801 Integration of immunotherapy into adjuvant therapy for resected NSCLC: ALCHEMIST chemo-IO (ACCIO)

• ALCHEMIST A151216

  Lung Cancer Not Accepting Patients

  Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)

• BRAT Prostate BRAchy Therapy Registry Trial

  Prostate Cancer Not Accepting Patients

  Prostate BRAchy Therapy Registry Trial